IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Displaying 121 - 140 of 158 stories.
December 9, 2009
A group of 25 companies from France and Brazil, including Rhodia, have made a joint commitment to develop industrial partnerships aimed at reducing emissions of greenhouse gases (GHG)...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/French-and-Brazilian-Firms-Collaborate-to-Cut-Greenhouse-Gas-Emissions_23361.html
October 26, 2009
Merck KGaA says its Pharma Raw Materials unit is expanding its activities and has divided the business, earlier this month, into two divisions; biopharma tools, and classical pharma...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/CPhI-Merck-KGaA-to-Add-Pharma-Production-Capacity-Mulls-China-Facility_22137.html
October 22, 2009
Lonza says it has signed an investment agreement, including a right of first refusal for the commercial production of products, with innovative biotechnology company Cilian...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Lonza-to-Acquire-Stake-in-German-Biotech-Firm_22240.html
October 2, 2009
Sanofi-Aventis (Paris) says it has entered into an exclusive global collaboration and licensing agreement with biotechnology company Merrimack Pharmaceuticals (Cambridge, MA) for...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Sanofi-Aventis-Signs-Licensing-Agreement-with-U-S-Biotech-Firm_21788.html
September 14, 2009
Biopharmaceutical company Amylin Pharmaceuticals (San Diego, CA) and biotechnology firm Biocon (Bangalore, India) say they have entered into an exclusive agreement to jointly develop...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Biocon-Amylin-Pharmaceuticals-in-Deal-for-Peptide-Hybrid_21331.html
August 27, 2009
Pfizer says it has opened a previously announced new facility for biotechnological pharmaceutical production at Strangnas, Sweden. Pfizer expects the plant, which was built with an...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Pfizer-Opens-Biotech-Plant-in-Sweden_21052.html
July 23, 2009
Sigma-Aldrich reported second-quarter earnings of 68 cts/share, compared to 70 cts/share in the year-ago period. The company's earnings for the first six months of 2009 totaled...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Sigma-Aldrichs-Earnings-Decline_20335.html
June 26, 2009
Lonza says it has signed a deal to produce therapeutic monoclonal antibody Anthim for biopharmaceutical company Elusys Therapeutics (Pine Brook, NJ). Anthim, which is in late-stage...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Lonza-Signs-Manufacturing-Deal-with-Biopharma-Firm_19832.html
June 15, 2009
The global market for fermentation ingredients is set to grow at a compound annual growth rate (CAGR) of 7%, leading to sales of $22.3 billion by the end of 2013, according to a report...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Fermentation-Ingredients-Market-Set-to-Hit-$22-3-Billionyear-by-2014-update_19567.html
June 2, 2009
DSM says it has entered into an agreement to acquire privately held biotechnology company Biopract (Berlin). Financial details of the deal were not disclosed. The acquisition of...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/DSM-Acquires-German-Biotech-Firm_19321.html
April 22, 2009
Venture capital investment in U.S. Biotech firms during the first quarter of the year fell 47%, compared with the year-ago period, to $3 billion, according to a report by...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Venture-Capital-Investment-in-U-S-Biotech-Hits-12-year-Low_18396.html
April 20, 2009
Microbia (Lexington, MA), a specialty chemicals company developing two carotenoid products, expects to commercialize its first two products by the end of 2010. The company recently...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Microbia-Preparing-for-Commercialization_18361.html
April 13, 2009
Synthetic biology firm Verdezyne (Carlsbad, CA) says it has signed a contract with Novozymes to optimize selected genes that encode industrial enzymes....
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Novozymes-Taps-Synthetic-Bio-Firm_18263.html
April 2, 2009
BASF says it has begun taking steps to commercialize a strain of Lactobacillus, a pro-biotic micro-organism, which it has engineered to protect against bacteria that cause cavities in...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/BASF-Commercializes-Bacteria-that-Cleans-Teeth_17969.html
March 19, 2009
Food ingredients giant Danisco has reported a loss of DK698 million ($123 million) for the company’s fiscal third quarter ended January 31. Corresponding sales were up 4% to...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Writedowns-Sour-Daniscos-Finances_17682.html
March 16, 2009
Wacker Chemie says it has opened a previously announced new process-development unit for the production of pharmaceutical proteins, or biologics, at Jena, Germany. The new unit...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Wacker-Opens-Process-Development-Unit-for-Biologics-in-Germany_17638.html
March 10, 2009
Merck & Co (Whitehouse Station, NJ) and Schering-Plough (Kenilworth, NJ) say their board of directors have approved a definitive merger agreement under which Merck will acquire...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Merck-and-Co-to-Acquire-Schering-Plough-for-$41-Billion_17517.html
February 23, 2009
Capturing the Potential of Innovation in Industrial Biotechnology (CLIB; Duesseldorf), a biotech innovation network featuring 60 member companies, is drawing industry interest by...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/German-Biotech-Network-Offers-New-Model-for-Innovation_17207.html
October 3, 2008
Lonza says it has entered into a global manufacturing, sales, and distribution agreement with biopharmaceutical company Crucell (Leiden, Netherlands) for Permexcis, a cell culture...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Lonza-Offers-Cell-Culture-Medium_14624.html
October 3, 2008
The University of Massachusetts Lowell (UMass) says it has opened a fully automated biopharma pilot plant and a lab, with equipment and services worth $600,000 donated by Invensys...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/UMass-Starts-Up-Biopharma-Pilot_14629.html
Pages: « Previous  1 2 3 4 5 6 [7] 8 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa